Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey
- 1k Downloads
Increasingly, medical school policies limit pharmaceutical representatives’ access to students and gifts from drugmakers, but little is known about how these policies affect student attitudes toward industry.
To assess interactions between trainees and the pharmaceutical industry, and to determine whether learning environment characteristics influence students’ practices and attitudes.
We conducted a cross-sectional survey with a nationally-representative sample of first- and fourth-year medical students and third-year residents, stratified by medical school, including ≥ 14 randomly selected trainees at each level per school.
We measured frequency of industry interactions and attitudes regarding how such interactions affect medical training and the profession. Chi-squared tests assessed bivariate linear trend, and hierarchical logistic regression models were fitted to assess associations between trainees’ attitudes and their schools’ National Institutes of Health (NIH) funding levels and American Medical Student Association (AMSA) PharmFree Scorecard grades reflecting industry-related conflict of interest policies.
Among 1,610 student (49.3 % response rate) and 739 resident (43.1 %) respondents, industry-sponsored gifts were common, rising from 33.0 % (first-year students) to 56.8 % (fourth-year students) and 54 % (residents) (p < 0.001). These gifts included meals outside the hospital (reported by 5 % first-year students, 13.4 % fourth-year students, 27.5 % residents (p < 0.001)) and free drug samples (reported by 7.4 % first-year students, 14.1 % fourth-year students, 14.3 % residents (p < 0.001)). The perception that industry interactions lead to bias was prevalent, but the belief that physicians receive valuable education through these interactions increased (64.1 % to 67.5 % to 79.8 %, p < 0.001). Students in schools receiving more NIH funding reported industry gifts less often (OR = 0.51, 95 % CI: 0.38–0.68, p < 0.001), but the strength of institutional conflict of interest policies was not associated with this variable.
Despite recent policy changes, a substantial number of trainees continue to receive gifts from pharmaceutical representatives. We found no relation between these outcomes and a school’s policies concerning interactions with industry.
KEY WORDSpharmaceutical industry undergraduate medical education drug promotion conflict of interest
The authors would like to thank Prof. Lawrence Lessig of Harvard Law School for his helpful comments on the study, and to acknowledge useful input from members of the Research Ethics Program of the Harvard Clinical and Translational Science Center. Study funded by a grant from the Edmond J. Safra Center for Ethics at Harvard University. Dr. Kesselheim is supported by a career development award from the Agency for Healthcare Research & Quality (K08HS18465-01), and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of Interest
The authors declare that they do not have a conflict of interest. Ms. Austad reports being a member of the American Medical Student Association (AMSA) and has received funding to support travel and lodging to attend AMSA conferences.
- 10.Fein E, Vermillion M, Uijtdehaag S. Pre-clinical medical students’ exposure to and attitudes toward pharmaceutical industry marketing. Med Educ. Online 2007;12. Available at: http://www.med-ed-online.net/index.php/meo/article/viewArticle/4465.
- 17.Institute of Medicine. Conflict of interest in medical research, education, and practice. Washington, D.C.: National Academies Press; 2009.Google Scholar
- 18.Association of American Medical Colleges. Industry funding of medical education: report of an AAMC task force. June 2008. Available at: https://members.aamc.org/eweb/upload/Industry%20Funding%20of%20Medical%20Education.pdf. Accessed 14 Jan 2013.
- 19.Stanford School of Medicine. New policy on continuing medical education. 19 Aug 2008. Available at: http://med.stanford.edu/coi/documents/deanpizzo_cmeletter.pdf. Accessed 14 Jan 2013.
- 20.Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. July 2008. Available at: http://www.phrma.org/sites/default/files/369/phrma_marketing_code_2008-1.pdf . Accessed 14 Jan 2013.
- 21.University of Iowa health care conflict of interests and conflict of commitment policy regarding interactions with industry. 20 January 2009. Available at: http://www.healthcare.uiowa.edu/cme/planning/documents/FinalCOIPolicy.pdf. Accessed 14 Jan 2013.
- 23.Kao AC, Braddock C 3rd, Clay M, Elliott D, Epstein SK, Filstead W, Hotze T, May W, Reenan J. Effect of educational interventions and medical school policies on medical students’ attitudes toward pharmaceutical marketing practices: a multi-institutional study. Acad Med. 2011;86(11):1454–1462.PubMedCrossRefGoogle Scholar
- 25.US News. Best medical schools: research. 2011. Available at: http://grad-schools.usnews.rankingsandreviews.com/best-graduate-schools/top-medical-schools/research-rankings. Accessed 14 Jan 2013.
- 26.American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. 2009. Available at: http://www.aapor.org/AM/Template.cfm?Section=Standard_Definitions1&Template=/CM/ContentDisplay.cfm&ContentID=1814. Accessed 14 Jan 2013.